SCM
VYNT

Sterneck Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Sterneck Capital Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-96
Closed -$25K – 126
2016
Q3 		$25K Sell
96
-2
-2% -$613 0.02% 118
2016
Q2 		$29K Sell
98
-3
-3% -$1.05K 0.02% 120
2016
Q1 		$43K Hold
101
– – 0.03% 118
2015
Q4 		$50K Sell
101
-33
-25% -$23.8K 0.03% 119
2015
Q3 		$157K Sell
134
-1
-0.7% -$1.53K 0.1% 113
2015
Q2 		$239K Sell
135
-245
-64% -$381K 0.13% 117
2015
Q1 		$445K Sell
380
-24
-6% -$28.4K 0.24% 83
2014
Q4 		$405K Sell
404
-2
-0.5% -$2K 0.24% 80
2014
Q3 		$548K Sell
406
-20
-5% -$28.6K 0.33% 71
2014
Q2 		$722K Sell
426
-32
-7% -$60.9K 0.42% 66
2014
Q1 		$1.04M Sell
458
-181
-28% -$463K 0.56% 57
2013
Q4 		$1.32M Buy
639
+150
+31% +$324K 0.8% 48
2013
Q3 		$1.49M Buy
+489
New +$837K 0.94% 37

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sterneck Capital Management's VYNT Position: Q4 2016 in Review

Sterneck Capital Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2016, closing a stake of 96 shares — an estimated $25K sold.

Sterneck Capital Management first reported a position in VYNT in Q3 2013 and held it in 13 quarters. The position peaked at $1.49M in Q3 2013. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2016.

  • Sterneck Capital Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Sterneck Capital Management sold 96 Vyant Bio, Inc. Common Stock shares in Q4 2016, an estimated $25K.
  • Sterneck Capital Management first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 13 quarters.
  • Sterneck Capital Management's Vyant Bio, Inc. Common Stock position peaked at $1.49M in Q3 2013.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2016.

Based on Sterneck Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.